首页> 外文OA文献 >Real-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapy

【2h】

Real-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapy

机译：在雄激素剥夺治疗之后，用次生激素疗法治疗的非转移前列腺癌患者的现实世界发病率和不良事件的负担

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Anuj Shah; Ruchit Shah; Nehemiah Kebede; Ateesha Mohamed; Marc Botteman; Reg Waldeck; Arif Hussain;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and Adverse Events of Intermittent Androgen Deprivation Therapy versus Continuos Androgen Deprivation Therapy on Localized and Metastatic Prostate Cancer: A Meta-Analysis [J] . Advanced Science Letters . 2018,第8期

机译：间歇性雄激素剥夺治疗的疗效和不良事件与局部和转移前列腺癌的连续雄激素剥夺治疗：荟萃分析
2. Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study [J] . Wu Lisa M., Tanenbaum Molly L., Dijkers Marcel P. J. M., Social science and medicine . 2016,第Null期

机译：雄激素剥夺治疗或观察治疗的非转移性前列腺癌患者的认知和神经行为症状：混合方法研究
3. A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients [J] . C Jin, Y Fan, Y Meng, Prostate Cancer and Prostatic Diseases . 2016,第4期

机译：对前列腺癌患者间歇性雄激素剥夺治疗与连续雄激素剥夺治疗中心血管事件的荟萃分析
4. Serum levels of sex hormones before and after androgen deprivation therapy in Japanese prostate cancer patients [C] . A. Komiya, K. Ichimatsu, A. Morii, International Congress of Andrology . 2009

机译：日本前列腺癌患者中雄激素剥夺治疗前后的性激素血清水平
5. Cost and Management of Fractures in Medicare Beneficiaries with Non-Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy. [D] . Yong, Candice Yuk Chen. 2015

机译：用雄激素剥夺疗法治疗的非转移性前列腺癌医疗保险受益人骨折的成本和管理。
6. Effectiveness of Vintage Hormone Therapy as Alternative Androgen Deprivation Therapy for Non-metastatic Castration-resistant Prostate Cancer [O] . HIROAKI IWAMOTO, HIROSHI KANO, TAKAFUMI SHIMADA, 2021

机译：复古激素治疗作为非转移性阉割前列腺癌的替代雄激素剥夺治疗的有效性
7. PCN137 ECONOMIC BURDEN ASSOCIATED WITH ADVERSE EVENTS AMONG PATIENTS WITH NON-METASTATIC PROSTATE CANCER TREATED WITH BICALUTAMIDE, ENZALUTAMIDE OR ABIRATERONE FOLLOWING ANDROGEN DEPRIVATION THERAPY (SURGICAL/MEDICAL CASTRATION) [O] . A. Shah, A. Hussain, R. Shah, 2019

机译：PCN137与雄蛋白化癌，苯甲醛或Abiraatorons治疗的非转移前列腺癌患者的不良事件相关的经济负担，如雄激素剥夺治疗（手术/医学阉割）

Real-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapy

著录项

引文网络

相似文献

相关主题

期刊订阅